
A 44-amino acid GHRH analog that stimulates pituitary gh secretion, studied for visceral adipose tissue reduction in clinical research.
Every lot is independently verified for identity (MS), purity (HPLC), appearance, and endotoxin. View the summary for the current lot, or request the full signed PDF by email.
Tesamorelin is a synthetic analogue of human Growth Hormone-Releasing Hormone (GHRH), a 44-amino acid hypothalamic peptide that stimulates pituitary somatotroph cells to secrete growth hormone (GH) via the GHRH receptor (GHRHR), a Gs-protein-coupled receptor. Unlike CJC-1295 (a truncated GHRH(1-29) analogue), tesamorelin retains the full 44-amino acid sequence of the endogenous hormone with an N-terminal trans-3-hexenoic acid modification that improves resistance to plasma dipeptidyl peptidase IV (DPP-IV) degradation. As a research compound, tesamorelin is used to study GHRH receptor binding kinetics, hypothalamic-pituitary GH axis signaling, and metabolic effects of GHRH receptor activation in preclinical and in vitro models.
All products sold by Next Level Research LLC are intended for laboratory and research use only. Not for human or animal consumption. Not a drug, food, or cosmetic. No therapeutic claims are made.